Biocon Limited (BOM:532523)
India · Delayed Price · Currency is INR 410.55
-7.90 (-1.89%)
At close: Jul 13, 2026
Biocon Revenue
In the fiscal year ending March 31, 2026, Biocon had annual revenue of 169.27B INR with 10.91% growth. Biocon had revenue of 45.17B in the quarter ending March 31, 2026, with 2.25% growth.
Revenue
169.27B
Revenue Growth
+10.91%
P/S Ratio
3.93
Revenue / Employee
10.31M
Employees
16,420
Market Cap
665.07B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 169.27B | 16.65B | 10.91% |
| Mar 31, 2025 | 152.62B | 5.06B | 3.43% |
| Mar 31, 2024 | 147.56B | 35.82B | 32.05% |
| Mar 31, 2023 | 111.74B | 29.90B | 36.54% |
| Mar 31, 2022 | 81.84B | 10.41B | 14.57% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aarti Drugs | 25.65B |
| Hester Biosciences | 3.34B |
| Titan Biotech | 2.06B |
| Zenotech Laboratories | 395.62M |
| Bharat Immunologicals & Biologicals Corporation | 76.50M |
| Hindustan Bio Sciences | 7.37M |
| Transgene Biotek | 2.11M |
| CCME Global | 350.00K |
Biocon News
- 12 days ago - Pharma sector stocks today, July 1: Panacea Biotec surges 4.30%, Biocon jumps 1.78%, Wockhardt up 1.66% - Business Upturn
- 13 days ago - Top stocks to buy: Stock market recommendations for today - check list - The Times of India
- 15 days ago - Kiran Mazumdar-Shaw calls Bengaluru 'garbage city', sparks debate - The Times of India
- 19 days ago - Biocon's partner Duopharma Biotech secures over MYR 225 million in insulin tenders in Malaysia - Business Upturn
- 20 days ago - Biocon announces 10% final dividend for FY 2025-26 with TDS details - Business Upturn
- 4 weeks ago - Accessing capital still difficult for women entrepreneurs today: Biocon founder Kiran Mazumdar-Shaw - The Times of India
- 4 weeks ago - Biocon invests Rs 5.47 crore in Ampin C&I Power Twelve for solar power stake - Business Upturn
- 7 weeks ago - Biocon issues reminder to shareholders for unclaimed dividends before August 2026 deadline - Business Upturn